Blenrep patent expiry?

When does the Blenrep (belantamab mafodotin) patent expire?

Blenrep’s patent expiry depends on the specific jurisdiction and the specific patent family (there are multiple patents covering different aspects such as the molecule, formulation, and method-of-use). The provided information doesn’t include the expiry dates or the patent numbers needed to state an exact “patent expiry” date for Blenrep.

What do people usually mean by “Blenrep patent expiry” (and why the answer can differ)?

Searchers often use “patent expiry” loosely to mean one of these timelines:
- the end of patent protection for the drug substance or key claims
- the end of exclusivity in a country (which can include non-patent exclusivity like data/market exclusivity)
- the date when generic or biosimilar manufacturers can launch “at risk” and then fully commercialize after additional legal barriers
Because those concepts are separate, the relevant date can differ even if the patent expiry itself is known.

How can you find the exact Blenrep patent expiry date you care about?

To get a precise expiry date, you typically need:
- the country (US, UK, EU, etc.)
- whether you mean the primary formulation/compound patent or later method-of-use patents
- the specific claim/patent family used for enforcement (often found in patent listings linked to the local regulatory system)

If you share the country (for example, “Blenrep UK” or “Blenrep US”) and whether you mean patent expiry or regulatory exclusivity, I can narrow the answer to the right timeline.

Could generic or competing versions enter before the last Blenrep patent ends?

Sometimes competitors can enter earlier through:
- launch of non-infringing alternatives
- challenges to patent validity or scope (litigation)
- regulatory pathways that allow earlier approval but delay commercialization until legal barriers are cleared
Which pathway applies to Blenrep depends on the local patent landscape and the specific patents in force in that jurisdiction.

What’s the fastest way to verify Blenrep expiry for a specific market?

Use the patent/exclusivity listings tied to the drug in that market’s regulatory or patent registry (these typically list the relevant patent numbers and end dates). If you tell me the jurisdiction you’re interested in, I can guide you to the exact place to look and what fields to match.

Sources

No sources were provided with your question.